Picture EBD Group World of Partnering Opportunities 650x100px
Collaboration › Details

Bruker–Leucadia: investor conference, 202306 supply service Brukers presents at Jefferies 2023 Healthcare Conference


Period Period 2023-06-09
Region Region New York, NY
  Country United States (USA)
Organisations Partner, 1st Bruker CALID Group
  Group Bruker (Group)
  Partner, 2nd Jefferies LLC
  Group Leucadia (Group)
Products Product Jefferies 2023 Global Healthcare Conference New York
  Product 2 analytical instrument
Persons Person Srega, Jürgen (Bruker 201302– President Bruker CALID Group before BRAHMS + Thermo Fisher Bremen)
  Person 2 Ward, Justin (Bruker 202204 Senior Director IR + Corporate Development)

Bruker Corporation. (6/2/23). "Press Release: Bruker Corporation to Present at Jefferies 2023 Healthcare Conference". Billerica, MA.

Bruker Corporation (Nasdaq: BRKR) announced today it will present at the Jefferies 2023 Healthcare Conference in New York on Friday, June 9, 2023 at 9:00 am EDT. Presenting for the company will be Juergen Srega, President of the Bruker CALID Group.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life-science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial research, semiconductor metrology and cleantech applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit:

Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 313-5800

Record changed: 2023-06-06


Picture Demy-Colton BioFuture 2024 NYC 3 Healthcare Revolution 650x200px

More documents for Bruker (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group World of Partnering Opportunities 650x300px

» top